Search

everythinglearnresearchcommunity

for

Search:↓

Polycystic Ovary Syndrome (PCOS) is a hormonal disorder in women that can cause infertility and other health issues, and it may be improved by treatments that increase insulin sensitivity.

A postmenopausal woman's excessive hair growth and hair loss were due to a non-cancerous ovarian condition, treated successfully with surgery.

Mostly postmenopausal Caucasian women get Frontal Fibrosing Alopecia, which often includes eyebrow loss and has limited treatment success.

Chlormadinone acetate is a strong, well-tolerated hormone used in birth control and hormone therapy with benefits for menstrual pain and skin conditions.

A 66-year-old man with a rare case of male frontal fibrosing alopecia did not regrow hair despite treatment.

Most patients with frontal fibrosing alopecia are middle-aged women, often have thyroid disease, and some treatments can help stabilize the condition.

Frontal Fibrosing Alopecia needs better diagnostics and treatments, with dutasteride showing promise.

Removing both ovaries can treat increased testosterone and related symptoms in postmenopausal women with ovarian hyperthecosis.

Clomiphene testing can help find ovarian causes of high testosterone in postmenopausal women.

Hair transplantation may not work for Frontal Fibrosing Alopecia as transplanted hair was lost when the disease came back.

Antiandrogen treatments combined with oral contraceptives can help manage hair growth and hair loss in women with PCOS.

Combination therapy, especially with finasteride, is effective for treating frontal fibrosing alopecia.

Frontal Fibrosing Alopecia may be linked to autoimmune diseases like Sjögren's syndrome.

A postmenopausal woman's hair loss and excess hair growth improved after surgery for ovarian hyperthecosis.

A woman with low thyroid function did not lose her hair during chemotherapy, possibly because her hair follicles were less affected by the treatment.

Low serum ferritin levels are not closely linked to telogen effluvium in women.

Iron deficiency is common in women regardless of hair loss, and treating it does not usually reverse hair loss.

Reticulocyte hemoglobin content is the best indicator of iron deficiency causing hair loss in women.

Effective treatment for midlife women's hair loss is limited, with 5% minoxidil foam being the only proven option for the most common type.

Hair and nail conditions can stabilize or improve over time, and new treatments show promise.

Finasteride at 2.5mg/day may help postmenopausal women with hair loss.

A woman's male-like symptoms and high testosterone were due to ovarian hilus-cell hyperplasia, which improved after surgery.

Excessive hair growth in women can be treated with medications like spironolactone and finasteride, and male-pattern baldness in women can be improved with similar treatments.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Women with type 1 diabetes often have polycystic ovary syndrome and excess male hormones, which are frequently undiagnosed.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

Finasteride improves hair density and thickness in women with hair loss.

Improving insulin sensitivity and weight loss can help manage polycystic ovary syndrome (PCOS).

The study found that women with PCOS have more and larger ovarian follicles and differences in ovarian structure, but these features alone can't always diagnose PCOS.